“소새울오피↘물뺄때는↗【 yeotop2 】 쩜 【 com 】소새울스파⊙소새울오피Ⅹ소새울키스방な소새울출장✄소새울풀싸롱✠소새울건마”的搜索结果，显示 111-120 项，共有 12100 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (10) advanced, unresectable multiple myeloma. Also eligible are (11) up ... A selected subset of participants (10 survivors and 10 caregivers) will be ...

3. 心血管医学- 临床试验- 妙佑医疗国际

   The purpose of this study is to establish a registry that will address the data gap regarding the course of NSTEMI (Non-ST-Elevation Myocardial Infarction) ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn., Jacksonville, Fla. The purpose of this study is to assess the safety of nonconforming lisocabtagene maraleucel in patients, and to assess the ...

5. 乳腺癌- 医生与科室- 妙佑医疗国际

   了解这种常见的癌症，包括有关预防、症状、诊断和治疗的信息。

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The primary objective of this study is to determine the confirmed investigator-assessed objective response rate of XMT-1536 (upifitamab rilsodotin) in ...